These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 13287015)

  • 1. [Effects of aluminum hydroxide on the immunizing properties of inactivated poliomyelitis vaccine].
    HAAS R; DOSTAL V; SAUTHOFF R
    Klin Wochenschr; 1955 Dec; 33(45-46):1082-4. PubMed ID: 13287015
    [No Abstract]   [Full Text] [Related]  

  • 2. Present status of immunization against poliomyelitis (Salk vaccine versus living, attenuated virus).
    WEISS C
    J Albert Einstein Med Cent (Phila); 1956 Sep; 4(4):159-60. PubMed ID: 13357446
    [No Abstract]   [Full Text] [Related]  

  • 3. [Report on the Salk vaccine].
    VIVELL
    Monatsschr Kinderheilkd (1902); 1956 Mar; 104(3):121-8. PubMed ID: 13321822
    [No Abstract]   [Full Text] [Related]  

  • 4. [Considerations for the implementation of the Salk vaccine].
    BUSTAMANTE W
    Rev Chil Pediatr; 1956 Mar; 27(3):123-7. PubMed ID: 13350716
    [No Abstract]   [Full Text] [Related]  

  • 5. [The Salk vaccine].
    DE ARAGAO RM
    J Pediatr (Rio J); 1955 Nov; 20(11):634-55. PubMed ID: 13294937
    [No Abstract]   [Full Text] [Related]  

  • 6. Further investigations on the immunogenic activity of aqueous and aluminum oxide adsorbed inactivated poliovirus vaccines in Macaca mulatta.
    Drescher J; Grützner L; Godglück G
    Am J Epidemiol; 1967 May; 85(3):413-23. PubMed ID: 4960865
    [No Abstract]   [Full Text] [Related]  

  • 7. Reactions to the salk polio vaccine injections of April 1955.
    DAVIS PL
    Med Times; 1956 Jul; 84(7):707-9. PubMed ID: 13347478
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of the Food and Drug Administration in the control of the Salk vaccine.
    CHECCHI AA
    Antibiot Chemother (Northfield); 1956 Apr; 6(4):257-9. PubMed ID: 24543956
    [No Abstract]   [Full Text] [Related]  

  • 9. Some results of the work on mass immunization in the Soviet Union with live poliovirus vaccine prepared from Sabin strains.
    CHUMAKOV MP
    Bull World Health Organ; 1961; 25(1):79-91. PubMed ID: 13879389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salk polio vaccine; comments concerning administration to allergic children.
    CRUMP J
    J Am Med Womens Assoc; 1956 Jul; 11(7):255. PubMed ID: 13345646
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: a phase I trial in healthy adults.
    Verdijk P; Rots NY; van Oijen MG; Oberste MS; Boog CJ; Okayasu H; Sutter RW; Bakker WA
    Vaccine; 2013 Nov; 31(47):5531-6. PubMed ID: 24063976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of Rh sensitivity after repeated injections of Salk vaccine.
    ABELSON NM; MCALLISTER RM; GREENE A; CORIELL LL
    J Am Med Assoc; 1955 Sep; 159(4):238-41. PubMed ID: 13251868
    [No Abstract]   [Full Text] [Related]  

  • 13. [The study of anti-poliomyelitis antibodies after vaccination with inactivated anti-poliomyelitis vaccine].
    LEONESCU M; BURLUI A; BUIMOVICI E; IANCONESCU M; PRECEAS L
    Stud Cercet Inframicrobiol; 1962; 13():97-102. PubMed ID: 14464108
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies onthe development of natural immunity to poliomyelitis in Louisiana. IV. Natural infections with polioviruses following immunization with a formalin-inactivated vaccine.
    GELFAND HM; LeBLANC DR; POTASH L; FOX JP
    Am J Hyg; 1959 Nov; 70():312-27. PubMed ID: 13827182
    [No Abstract]   [Full Text] [Related]  

  • 15. Early immunization with inactivated poliovirus vaccine in premature infants.
    Linder N; Yaron M; Handsher R; Kuint J; Birenbaum E; Mazkereth R; Lubin D; Mendelson E; Safrir O; Reichman B
    J Pediatr; 1995 Jul; 127(1):128-30. PubMed ID: 7608797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-poliomyelitis vaccination with inactivated virus (Lepine vaccine). Effect of the booster injection on immunization].
    MARTIN R; ROGER F; DAMAS JP; ROGER A; JUILLARD P
    Bull Acad Natl Med; 1961 Nov 21-28; 145():664-73. PubMed ID: 14470436
    [No Abstract]   [Full Text] [Related]  

  • 17. A community vaccination program. A report on the introduction and subsequent use of Salk polio vaccine in Omaha and Douglas County.
    LYMAN ED; ADAMS B
    Nebr State Med J; 1962 May; 47():290-6. PubMed ID: 14467569
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of the immunogenic properties of inactivated poliomyelitis vaccine by single vaccination of small laboratory animals (guinea pigs, chickens and white rats).
    GHENDON IZ; MARSCHENKO AT
    J Hyg Epidemiol Microbiol Immunol; 1961; 5():320-9. PubMed ID: 13898182
    [No Abstract]   [Full Text] [Related]  

  • 19. [Certain experiences with the preparation of the inactivated poliomyelitis vaccine in CSR. II. Preparation of the medium].
    SLONIM D; MICHL J; CINNEROVA O; MARES I; DREVO M
    Cesk Epidemiol Mikrobiol Imunol; 1960 Mar; 9():111-21. PubMed ID: 13831709
    [No Abstract]   [Full Text] [Related]  

  • 20. [On neutralizing antibodies before and after vaccination against poliomyelitis with Salk vaccine].
    GILLERT KE; GRUETZNER L; HARTMANN H
    Zentralbl Bakteriol; 1960 Feb; 177():289-98. PubMed ID: 13850076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.